Testosterone Enanthate Cost in North Dakota (2026): Cash Prices, Insurance, and Savings Options

What Testosterone Enanthate Actually Costs in North Dakota Right Now

The average cash-pay price for testosterone enanthate at North Dakota retail pharmacies sits at roughly $70 per month in 2026, based on a standard once-weekly intramuscular injection protocol. Manufacturer list pricing runs higher at around $120 per month, but very few patients pay that figure out of pocket.

Pricing varies depending on which pharmacy you visit, the specific manufacturer, and your prescribed dose. A 1 mL vial of testosterone enanthate 200 mg/mL from a generic manufacturer typically costs between $40 and $90 across Fargo, Bismarck, Grand Forks, and Minot pharmacies. Multi-dose 5 mL vials drop the per-dose cost further. Walmart, Costco (no membership needed for pharmacy), and independent pharmacies in ND tend to price generics lower than chain pharmacies like CVS or Walgreens.

The T-Trials, a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine (N=790 men aged 65 and older with low testosterone), demonstrated that testosterone gel treatment for one year improved sexual function, physical function, and bone mineral density compared to placebo 1. While those trials used transdermal gel rather than enanthate injections, the clinical rationale for testosterone replacement applies across formulations, and injectable enanthate remains the most cost-effective delivery method by a wide margin.

Patients filling a prescription without insurance should always compare prices across at least three pharmacies. Price differences of $20 to $40 for the same generic vial are common even within the same city.

North Dakota Medicaid and Testosterone Enanthate: Coverage Gap Explained

North Dakota Medicaid does not cover testosterone enanthate for the diagnosis of male hypogonadism as of 2026. This creates a real access barrier for low-income men who qualify for Medicaid but need testosterone replacement therapy (TRT).

The coverage exclusion applies specifically to testosterone replacement for primary or secondary hypogonadism in adult males. North Dakota's Medicaid preferred drug list categorizes androgens as non-preferred, and prior authorization requests for testosterone enanthate in male patients are routinely denied. This is not unique to North Dakota. Several states exclude or restrict androgen coverage under Medicaid, citing cost containment and formulary management.

For Medicaid enrollees who have a clinical diagnosis of hypogonadism confirmed by two morning total testosterone levels below 300 ng/dL, as recommended by the American Urological Association (AUA) guidelines, the lack of Medicaid coverage means paying cash. At $70 per month average, this adds up to $840 per year. That amount, while manageable for some, represents a significant burden for patients who qualified for Medicaid in the first place.

Some patients in this situation turn to compounded testosterone enanthate from 503A pharmacies or manufacturer assistance programs to reduce their out-of-pocket costs. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism and unequivocally low testosterone, regardless of the specific formulation used, which supports the medical necessity of treatment even when a state formulary excludes it.

Commercial Insurance Coverage in North Dakota

Most major commercial insurance plans available in North Dakota, including Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica, cover generic testosterone enanthate with prior authorization. The typical out-of-pocket cost with commercial insurance falls between $10 and $30 per month for a generic injectable.

Prior authorization requirements generally include documentation of two separate morning serum total testosterone levels below 300 ng/dL drawn between 7 AM and 10 AM, signs and symptoms consistent with hypogonadism (fatigue, decreased libido, erectile dysfunction, loss of muscle mass), and exclusion of reversible causes such as opioid use, obesity, or pituitary pathology. The FDA-approved prescribing information for testosterone enanthate specifies its indication for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone.

Employer-sponsored plans through large North Dakota employers such as Bobcat (Doosan), Basin Electric, and Sanford Health typically include injectable testosterone on their pharmacy formularies at a Tier 2 or Tier 3 copay level. Self-insured employer plans may have different formulary structures, so patients should verify coverage by calling the number on their pharmacy benefit card.

Dr. Shalender Bhasin, principal investigator of the T-Trials, has stated: "Testosterone treatment should be considered for symptomatic men with unambiguously low testosterone levels after a thorough diagnostic evaluation" 1. This clinical consensus strengthens the case when submitting prior authorization appeals to North Dakota insurers.

For patients whose initial PA is denied, a letter of medical necessity from the prescribing provider referencing the Endocrine Society guidelines and documenting failed non-pharmacological interventions (weight loss, sleep optimization, discontinuation of offending medications) significantly improves appeal success rates.

Compounded Testosterone Enanthate in North Dakota: Legal and Available

Compounded testosterone enanthate is legal in North Dakota when dispensed by a state-licensed 503A compounding pharmacy pursuant to a valid patient-specific prescription. The average cost runs approximately $80 per month.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound medications for individual patients based on prescriptions from licensed practitioners. North Dakota's Board of Pharmacy regulates these pharmacies under NDCC Chapter 43-15 and requires compliance with USP <797> sterile compounding standards. Patients filling compounded testosterone enanthate should confirm that their pharmacy holds a current ND compounding license and follows USP <797> guidelines for sterile preparations.

Why would compounded testosterone cost $80 per month when generic retail costs $70? The answer is nuanced. Compounded formulations can be customized to specific concentrations (e.g., 250 mg/mL instead of the standard 200 mg/mL), combined with other compounds, or prepared in different carrier oils for patients who react to the cottonseed or sesame oil in commercial products. Some patients also prefer compounded options because a single multi-dose vial can last 10 to 12 weeks, reducing per-visit pharmacy costs.

A 2020 study published in the Journal of the Endocrine Society found that compounded testosterone products represented approximately 18% of all testosterone prescriptions in the United States, with cost savings varying by region and formulation 2. North Dakota patients can access compounded testosterone from both in-state pharmacies and out-of-state 503A pharmacies that ship to ND, provided the prescription originates from a provider licensed in North Dakota or holding a valid ND telehealth registration.

The important distinction: 503B outsourcing facilities operate differently from 503A pharmacies. They can produce larger batches without patient-specific prescriptions, but they are subject to FDA oversight similar to drug manufacturers. Both pathways are legal in North Dakota for testosterone enanthate.

Telehealth TRT in North Dakota: How It Works and What It Costs

North Dakota permits telehealth prescribing of testosterone enanthate, and several national TRT platforms operate in the state. Telehealth visits for TRT typically cost between $99 and $199 for an initial consultation, with follow-up visits ranging from $50 to $150.

The North Dakota Board of Medicine allows physicians and advanced practice providers to prescribe controlled substances via telehealth after establishing a valid provider-patient relationship through a real-time audio-visual encounter. This aligns with the DEA's telehealth prescribing framework that was updated following the COVID-19 public health emergency flexibilities.

Telehealth TRT platforms bundle their services differently. Some include lab work, provider visits, and medication in a monthly subscription ($150 to $250 per month all-in). Others charge separately for consultations and have patients fill prescriptions at their local pharmacy, where they can use insurance or discount cards. For North Dakota patients comparing options, the total monthly cost breaks down roughly like this:

Telehealth subscription model (all-inclusive): $150 to $250 per month. Telehealth consultation plus local pharmacy fill: $50 to $75 for the visit (amortized quarterly) plus $70 for medication, totaling approximately $85 to $95 per month. Traditional in-office visit with insurance: $10 to $30 copay for medication plus periodic office visit copays.

A 2021 analysis in Urology of direct-to-consumer testosterone clinics found wide variability in pricing, lab monitoring protocols, and prescribing practices. The authors recommended that patients verify their telehealth provider orders baseline and follow-up labs including total testosterone, free testosterone, hematocrit, PSA (for men over 40), and lipid panels, consistent with Endocrine Society monitoring guidelines.

North Dakota residents in rural areas benefit disproportionately from telehealth TRT access. With endocrinologists and urologists concentrated in Fargo, Bismarck, and Grand Forks, patients in western ND may face 2-to-4-hour drives for in-person visits. Telehealth eliminates that barrier entirely.

Discount Programs and Savings Strategies for North Dakota Patients

Multiple discount pathways exist for North Dakota patients paying cash for testosterone enanthate. The most effective approach combines several strategies.

GoodRx, RxSaver, and SingleCare discount cards are accepted at nearly every North Dakota pharmacy, including Walmart, Walgreens, CVS, Thrifty White, and independent pharmacies. These cards typically reduce the cash price of generic testosterone enanthate 200 mg/mL (1 mL vial) to between $25 and $55 per fill. Prices fluctuate, so checking all three platforms before each fill is worth the 60 seconds it takes. The cards are free. There is no enrollment or income requirement.

Manufacturer savings cards from brand-name testosterone enanthate producers (Endo Pharmaceuticals' Delatestryl, for instance) occasionally offer copay assistance for commercially insured patients, reducing out-of-pocket costs to as low as $0 to $25. These programs exclude government insurance beneficiaries (Medicaid, Medicare, Tricare, VA) per federal anti-kickback statute requirements.

For uninsured patients, the NeedyMeds database and state pharmaceutical assistance programs provide additional options. North Dakota does not operate a standalone state pharmaceutical assistance program, but the ND Department of Health and Human Services can direct patients to federal programs like the 340B Drug Pricing Program, which certain ND federally qualified health centers (FQHCs) participate in.

Buying a 10 mL multi-dose vial instead of individual 1 mL vials cuts the per-dose cost by 40% to 60% at most pharmacies. A 10 mL vial of testosterone enanthate 200 mg/mL typically costs $80 to $120 cash and provides 10 weeks of treatment at 200 mg per week. That works out to $8 to $12 per week. At the 1 mL vial price of $40 to $90 each, weekly dosing costs $40 to $90 per week. The math strongly favors multi-dose vials for patients on stable doses.

How Testosterone Enanthate Pricing Compares to Other TRT Options in ND

Testosterone enanthate at $70 per month cash is the most affordable TRT formulation available in North Dakota. Other options cost significantly more.

Testosterone cypionate, the other common injectable ester, costs roughly the same as enanthate ($65 to $80 per month cash) and is clinically interchangeable. The two esters have nearly identical half-lives (approximately 8 days for enanthate vs. 8 to 12 days for cypionate) and produce equivalent steady-state testosterone levels on weekly injection schedules 3.

Testosterone gel (AndroGel, Testim, Vogelxo, or generic) costs $200 to $500 per month cash. Insurance copays bring that down, but even with commercial coverage, gels typically run $30 to $75 per month at Tier 2 or Tier 3 copay. Testosterone patches (Androderm) cost $300 to $600 per month cash. Nasal testosterone (Natesto) exceeds $500 per month. And testosterone pellet implants (Testopel) cost $500 to $1,000 per insertion every 3 to 6 months, plus the procedure fee.

A 2019 cost-effectiveness analysis published in the Journal of Urology found that injectable testosterone (enanthate or cypionate) delivered the lowest annual treatment cost among all TRT formulations while producing equivalent clinical outcomes in terms of symptom improvement and testosterone level normalization. The study estimated annual injectable TRT costs at $480 to $1,200, compared to $2,400 to $6,000 for topical formulations.

For North Dakota patients making a purely economic decision, injectable enanthate or cypionate is the clear winner. The tradeoff is self-injection, which most patients learn within one or two supervised sessions at their provider's office.

Lab Monitoring Costs to Factor Into Your TRT Budget

TRT requires periodic blood work, and those lab costs should be part of your total cost calculation. Initial workup and ongoing monitoring add $200 to $600 per year depending on insurance status and lab provider choice.

The Endocrine Society guideline recommends measuring total testosterone, hematocrit, and PSA (in men over 40) at baseline, then at 3 to 6 months after starting therapy, and annually thereafter. Additional labs commonly ordered include free testosterone, estradiol, lipid panel, liver function tests, and a complete metabolic panel.

For uninsured North Dakota patients, direct-to-consumer lab services (Quest Diagnostics via QuestDirect, LabCorp via Pixel, or online platforms like Walk-In Lab) offer testosterone panels for $50 to $100 without a separate provider order. Traditional lab draws billed through a clinic may cost $150 to $400 without insurance.

Hematocrit monitoring is especially important. A meta-analysis of 15 randomized controlled trials found that testosterone therapy increased hematocrit by a mean of 2.8% compared to placebo, with clinically significant polycythemia (hematocrit >54%) occurring in 5% to 8% of treated men. North Dakota's elevation is modest (average 1,600 feet), so altitude-driven polycythemia is not a major concern here, but smoking and obstructive sleep apnea are compounding risk factors that providers should screen for.

The AUA guideline states: "Clinicians should monitor hematocrit at 3 to 6 months after initiating testosterone therapy and then annually. If hematocrit rises above 54%, clinicians should stop testosterone therapy and evaluate the patient" 4. Include at least two lab draws per year in your annual TRT budget, at roughly $75 to $150 per draw for uninsured patients using a direct-to-consumer platform.